Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hearing Science Accelerator: Sudden Sensorineural Hearing Loss-Executive Summary of Research Initiatives.
Slattery WH 3rd, Andalibi A, Angeli S, Babu S, Bolt K, Britt W, Buckey JC Jr, Butman J, Chandrasekhar S, Fernandez K, Haynes D, Hertzano R, Hirose K, Hoa M, Hodge S, Howard M, Lalwani A, Liotta L, Luchini A, de Oliveira Penido N, Parham K, Plontke S, Quesnel A, Rauch SD, Saunders J, Schlingensiepen R, Schwartz S, Stewart DR, Vambutas A, Westerberg B, Andresen N. Slattery WH 3rd, et al. Among authors: schlingensiepen r. Otol Neurotol. 2024 Dec 1;45(10):e670-e678. doi: 10.1097/MAO.0000000000004341. Epub 2024 Oct 28. Otol Neurotol. 2024. PMID: 39473327 No abstract available.
A single dose of AC102 restores hearing in a guinea pig model of noise-induced hearing loss to almost prenoise levels.
Rommelspacher H, Bera S, Brommer B, Ward R, Kwiatkowska M, Zygmunt T, Theden F, Üsekes B, Eren N, Nieratschker M, Arnoldner C, Plontke SK, Hellmann-Regen J, Schlingensiepen R. Rommelspacher H, et al. Among authors: schlingensiepen r. Proc Natl Acad Sci U S A. 2024 Apr 9;121(15):e2314763121. doi: 10.1073/pnas.2314763121. Epub 2024 Apr 1. Proc Natl Acad Sci U S A. 2024. PMID: 38557194 Free PMC article.
A preoperative dose of the pyridoindole AC102 improves the recovery of residual hearing in a gerbil animal model of cochlear implantation.
Nieratschker M, Yildiz E, Gerlitz M, Bera S, Gadenstaetter AJ, Kramer AM, Kwiatkowska M, Mistrik P, Landegger LD, Braun S, Schlingensiepen R, Honeder C, Arnoldner C, Rommelspacher H. Nieratschker M, et al. Among authors: schlingensiepen r. Cell Death Dis. 2024 Jul 26;15(7):531. doi: 10.1038/s41419-024-06854-9. Cell Death Dis. 2024. PMID: 39060244 Free PMC article.
Silicone-based AC102-loaded cochlear implant coatings protect residual hearing in an animal model of cochlear implantation.
Nieratschker M, Mistrik P, Petrasek Z, Yildiz E, Gadenstaetter AJ, Gerlitz M, Kramer AM, Kwiatkowska M, Braun S, Schlingensiepen R, Honeder C, Arnoldner C. Nieratschker M, et al. Among authors: schlingensiepen r. Hear Res. 2024 Dec;454:109150. doi: 10.1016/j.heares.2024.109150. Epub 2024 Nov 12. Hear Res. 2024. PMID: 39549622 Free article.
Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticaria.
Magerl M, Rother M, Bieber T, Biedermann T, Brasch J, Dominicus R, Hunzelmann N, Jakob T, Mahler V, Popp G, Schäkel K, Schlingensiepen R, Schmitt J, Siebenhaar F, Simon JC, Staubach P, Wedi B, Weidner C, Maurer M. Magerl M, et al. Among authors: schlingensiepen r. J Eur Acad Dermatol Venereol. 2013 Mar;27(3):e363-9. doi: 10.1111/j.1468-3083.2012.04689.x. Epub 2012 Aug 29. J Eur Acad Dermatol Venereol. 2013. PMID: 22928719 Clinical Trial.
Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies.
Hau P, Jachimczak P, Schlingensiepen R, Schulmeyer F, Jauch T, Steinbrecher A, Brawanski A, Proescholdt M, Schlaier J, Buchroithner J, Pichler J, Wurm G, Mehdorn M, Strege R, Schuierer G, Villarrubia V, Fellner F, Jansen O, Straube T, Nohria V, Goldbrunner M, Kunst M, Schmaus S, Stauder G, Bogdahn U, Schlingensiepen KH. Hau P, et al. Among authors: schlingensiepen r. Oligonucleotides. 2007 Summer;17(2):201-12. doi: 10.1089/oli.2006.0053. Oligonucleotides. 2007. PMID: 17638524 Clinical Trial.
Targeted tumor therapy with the TGF-beta 2 antisense compound AP 12009.
Schlingensiepen KH, Schlingensiepen R, Steinbrecher A, Hau P, Bogdahn U, Fischer-Blass B, Jachimczak P. Schlingensiepen KH, et al. Among authors: schlingensiepen r. Cytokine Growth Factor Rev. 2006 Feb-Apr;17(1-2):129-39. doi: 10.1016/j.cytogfr.2005.09.002. Epub 2005 Dec 27. Cytokine Growth Factor Rev. 2006. PMID: 16377233 Review.
20 results